$51.68
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NasdaqGS:INCY
Incyte Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $131.20 | $130.51 | 0.00% | 11 | $321.69B |
| ABBV | AbbVie | NYSE | Outperform | $159.62 | $178.42 | 0.00% | 11 | $282.63B |
| AZN | AstraZeneca PLC | LSE | Outperform | £119.88 | £165.99 | 0.00% | 16 | £186.43B |
| NOVN | Novartis | SWX | Hold | CHF89.50 | CHF105.00 | 0.00% | 9 | CHF181.47B |
| ROG | Roche Holding | SWX | Hold | CHF221.00 | CHF307.83 | 0.00% | 9 | CHF178.76B |
| AMGN | Amgen | NasdaqGS | Outperform | $269.98 | $303.65 | 0.00% | 8 | $144.81B |
| SAN | Sanofi | ENXTPA | Outperform | 91.23€ | 102.80€ | 0.00% | 9 | 109.51€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $883.20 | $961.26 | 0.00% | 8 | $96.37B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.85 | $58.15 | 0.00% | 10 | $90.60B |
| GSK | GSK | LSE | Outperform | £16.53 | £17.30 | 0.00% | 12 | £67.54B |
| MRK | Merck KGaA | XTRA | Outperform | 151.75€ | 190.06€ | 0.00% | 4 | 63.48€B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.09k | ¥4.74k | 0.00% | 0 | ¥6.38T |
| 4523 | Eisai | TSE | Outperform | ¥6.24k | ¥9.58k | 0.00% | 0 | ¥1.69T |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $109.46 | $188.32 | 0.00% | 4 | $6.85B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $41.59 | $55.60 | 0.00% | 3 | $6.37B |
| EXEL | Exelixis | NasdaqGS | Outperform | $23.70 | $26.44 | 0.00% | 5 | $6.21B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $49.86 | $79.81 | 0.00% | 3 | $5.73B |
| MOR | MorphoSys | XTRA | Outperform | 67.85€ | 28.78€ | 0.00% | 3 | 2.55€B |
| GERN | Geron | NasdaqGS | Buy | $3.79 | $4.83 | 0.00% | 1 | $1.06B |
| PGEN | Precigen | NasdaqGS | Outperform | $1.41 | $9.46 | 0.00% | 2 | $331.06M |
| OMER | Omeros | NasdaqGM | Hold | $3.15 | $13.00 | 0.00% | 2 | $282.89M |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $1.17 | $3.26 | 0.00% | 1 | $158.26M |
| KPTI | Karyopharm Therapeutics | NasdaqGS | Outperform | $1.06 | $6.00 | 0.00% | 1 | $134.63M |
| DXB | Dimerix | ASX | $0.32 | $0.00 | 0.00% | 0 | $159.38M | |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.33 | $9.44 | 0.00% | 2 | $79.49M |
| BLRX | BioLineRx | TASE | - | ₪0.17 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.19 | $80.00 | 0.00% | 0 | $9.39M |
